INTEC PHARMA LTD. Financing Cash Flow
INTEC PHARMA LTD. reported Financing Cash Flow of $956.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2021-05-17
- INTEC PHARMA LTD. net cash provided by (used in) financing activities for the quarter ending 2021-03-31 was $956.00K, a 84.36% decline year-over-year.
- INTEC PHARMA LTD. net cash provided by (used in) financing activities for the quarter ending 2020-12-31 was $71.00K, a 45.80% decline year-over-year.
- INTEC PHARMA LTD. net cash provided by (used in) financing activities for the quarter ending 2020-09-30 was $5.30M, a 169.32% increase year-over-year.
- INTEC PHARMA LTD. net cash provided by (used in) financing activities for the quarter ending 2020-06-30 was $4.49M, a 4097.20% increase year-over-year.
- INTEC PHARMA LTD. net cash provided by (used in) financing activities for fiscal 2020 was $15.98M, a 574.75% increase from fiscal 2019.
- INTEC PHARMA LTD. net cash provided by (used in) financing activities for fiscal 2019 was $2.37M, a 93.25% decline from fiscal 2018.
- INTEC PHARMA LTD. net cash provided by (used in) financing activities for fiscal 2018 was $35.06M, a 44.97% decline from fiscal 2017.
- INTEC PHARMA LTD. net cash provided by (used in) financing activities for fiscal 2017 was $63.71M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2021-03-31 | $956.00K 10-Q · filed 2021-05-17 | $1.03M derived: sum of 2 quarters · filed 2021-05-17 | $6.33M derived: sum of 3 quarters · filed 2021-05-17 | $10.82M derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-12-31 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $5.37M derived: sum of 2 quarters · filed 2021-03-16 | $9.87M derived: sum of 3 quarters · filed 2021-03-16 | $15.98M 10-K · filed 2021-03-16 |
| 2020-09-30 | $5.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $9.79M derived: sum of 2 quarters · filed 2020-11-05 | $15.91M 10-Q · filed 2020-11-05 | $16.04M derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-06-30 | $4.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $10.60M 10-Q · filed 2020-08-05 | $10.73M derived: sum of 3 quarters · filed 2021-05-17 | $12.70M derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-03-31 | $6.11M 10-Q · filed 2021-05-17 | $6.24M derived: sum of 2 quarters · filed 2021-05-17 | $8.21M derived: sum of 3 quarters · filed 2021-05-17 | $8.32M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $2.10M derived: sum of 2 quarters · filed 2021-03-16 | $2.21M derived: sum of 3 quarters · filed 2021-03-16 | $2.37M 10-K · filed 2021-03-16 |
| 2019-09-30 | $1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.08M derived: sum of 2 quarters · filed 2020-11-05 | $2.24M 10-Q · filed 2020-11-05 | $2.27M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $268.00K 10-Q · filed 2020-08-05 | $297.00K derived: sum of 3 quarters · filed 2020-08-05 | $297.00K derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $161.00K 10-Q · filed 2020-05-11 | $190.00K derived: sum of 2 quarters · filed 2020-05-11 | $190.00K derived: sum of 3 quarters · filed 2020-05-11 | |
| 2018-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $29.00K derived: sum of 2 quarters · filed 2020-03-13 | $35.06M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $35.03M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $35.03M 10-Q · filed 2019-08-09 | |||
| 2017-12-31 | $63.71M 10-K · filed 2019-02-27 |